Xtant Medical Holdings, Inc. received a $10.7 million payment from Companion Spine on February 27, 2026. This payment included the full repayment of an $8.2 million unsecured promissory note, accrued interest thereon, and settlement of net working capital and other purchase price adjustments under the Paradigm purchase agreement. The total aggregate purchase price for the divestitures of Coflex and CoFix products and Paradigm Spine GmbH now stands at $21.4 million, an increase from the previously announced $19.2 million. $2.8 million of the received funds were used to prepay a portion of the company's term loan with MidCap Financial Trust. The remaining principal outstanding on the term loan is $11.1 million as of the date of the filing.